By Greg Ryan ( March 11, 2013, 8:37 PM EDT) -- By settling a Tenth Circuit challenge to its victory in an antidepressant suicide-warning case Friday, Pfizer Inc. may have forfeited the pharmaceutical industry's best shot at advancing the finding that federal law preempts some failure-to-warn claims over brand-name drugs, attorneys say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.